Efficacy of montelukast in the treatment of nasal polyposis

Annals of Otology, Rhinology and Laryngology

Volumn 114, Issue 12 I, 2005, Pages 941-945

  Kieff, David A ^a,b,c   Busaba, Nicolas Y ^a,b  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD VANGUARD MEDICAL ASSOCIATES   (United States)

Author keywords

Chronic sinusitis; Eosinophilia; Montelukast; Nasal polyposis; Rhinitis; Symptom score

Indexed keywords

MONTELUKAST; STEROID;

ABDOMINAL CRAMP; ARTICLE; CHRONIC DRUG ADMINISTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; EOSINOPHILIA; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN TISSUE; NASAL BIOPSY; NOSE POLYP; PERENNIAL RHINITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RASH; SCORING SYSTEM; STEROID THERAPY; SYMPTOMATOLOGY; TREATMENT OUTCOME; VALIDATION PROCESS;

EID: 29744468977     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940511401209     Document Type: Article

References (24)

1. Settipane GA, Chafee FH. Nasal polyps in asthma and rhinitis. A review of 6,037 patients. J Allergy Clin Immunol 1977;59:17-21.
2. Singh H, Ballow M. Role of cytokines in nasal polyposis. J Investig Allergol Clin Immunol 2003;13:6-11.
3. Mygind N. Advances in the medical treatment of nasal polyps. Allergy 1999;54(suppl 53):12-6.
4. Scadding GK. Comparison of medical and surgical treatment of nasal polyposis. Curr Allergy Asthma Rep 2002;2:494-9.
5. Haye R, Aanesen JP, Burtin B, Donnelly F, Duby C. The effect of cetirizine on symptoms and signs of nasal polyposis. J Laryngol Otol 1998;112:1042-6.
6. Singulair (montelukast) product circular. Whitehouse Station, NJ: Merck & Co, Inc.
7. Nayak AS, Philip G, Lu S, Malice RP, Reiss TF; Montelukast Fall Rhinitis Investigator Group. Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall. Ann Allergy Asthma Immunol 2002;88:592-600.
8. Philip G, Malmstrom K, Hampel FC. Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring. Clin Exp Allergy 2002;32:1020-8.
9. Sousa AR, Parikh A, Scadding G, Corrigan CJ, Lee TH. Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. N Engl J Med 2002;347:1493-9.
10. Arango P, Borish L, Frierson HF Jr, Kountakis SE. Cysteinyl leukotrienes in chronic hyperplastic rhinosinusitis. Otolaryngol Head Neck Surg 2002;127:512-5.
11. Ulualp SO, Sterman BM, Toohill RJ. Antileukotriene therapy for the relief of sinus symptoms in aspirin triad disease. Ear Nose Throat J 1999;78:604-6, 608, 613.
12. Lund VJ, Kennedy DW. Quantification for staging sinusitis. The Staging and Therapy Group. Ann Otol Rhinol Laryngol Suppl 1995;104(suppl 167):17-21.
13. Hedman J, Kaprio J, Poussa T, Nieminen MM. Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. Int J Epidemiol 1999;28:717-22.
14. Rugina M, Serrano E, Klossek JM, et al. Epidemiological and clinical aspects of nasal polyposis in France; the ORLI group experience. Rhinology 2002;40:75-9.
15. Larsen K, Tos M. The estimated incidence of symptomatic nasal polyps. Acta Otolaryngol (Stockh) 2002;122:179-82.
16. Tuncer U, Soylu L, Aydogan B, Karakus F, Akcali C. The effectiveness of steroid treatment in nasal polyposis. Auris Nasus Larynx 2003;30:263-8.
17. Nayak AS. A common pathway: asthma and allergic rhinitis. Allergy Asthma Proc 2002;23:359-65.
18. Ponikau JU, Sherris DA, Kephart GM, et al. Features of airway remodeling and eosinophilic inflammation in chronic rhinosinusitis: is the histopathology similar to asthma? J Allergy Clin Immunol 2003;112:877-82.
19. Montelukast (Singulair) for allergic rhinitis. Med Lett Drugs Ther 2003;45:21-2.
20. Hilberg O, Jackson AC, Swift DL, Pedersen OF. Acoustic rhinometry: evaluation of nasal cavity by acoustic reflection. J Appl Physiol 1989;66:295-303.
21. Broms P, Ivarsson A, Johnson B. Rhinomanometry I. Simple equipment. Acta Otolaryngol (Stockh) 1982;93:455-60.
22. Clarke RW, Jones AS. The limitations of peak nasal flow measurement. Clin Otolaryngol Allied Sci 1994;19:502-4.
23. Stewart MG, Sicard MW, Piccirillo JF, Diaz-Marchan PJ. Severity staging in chronic rhinosinusitis: are CT findings related to patient symptoms? Am J Rhinol 1999;13:161-7.
24. Bhattacharyya N. A comparison of symptom scores and radiographic staging symptoms in chronic rhinosinusitis. Am J Rhinol 2005;19:175-9.